@prefix adms: <http://www.w3.org/ns/adms#> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix dcatap: <http://data.europa.eu/r5r/> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dpv: <https://w3id.org/dpv#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix healthdcatap: <http://healthdataportal.eu/ns/health#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix vcard: <http://www.w3.org/2006/vcard/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://fdp-zin.dci.thehyve.nl/dataset/96e301b9-31cc-44f8-a9b5-0755fd8ae88e> a dcat:Dataset ;
    dcatap:applicableLegislation <http://example.org/unknown> ;
    healthdcatap:healthCategory <https://www.wikidata.org/wiki/Q112861019>,
        <https://www.wikidata.org/wiki/Q180614> ;
    dct:accessRights <http://publications.europa.eu/resource/authority/access-right/PUBLIC> ;
    dct:creator [ a foaf:Agent ;
            dct:identifier <http://zorginstituutnederland.nl> ;
            vcard:hasEmail <mailto:info@zin.nl> ;
            foaf:homepage <https://www.zorginstituutnederland.nl/> ;
            foaf:name "Zorginstituut Nederland" ] ;
    dct:description ""@en,
        "Het Zorginstituut adviseert om dit middel niet te vergoeden voor de beoordeelde indicatie."@nl ;
    dct:identifier "1a40a1de425382d7a524bf36b5cd17f1" ;
    dct:issued "2026-03-06T10:38:32.612394"^^xsd:dateTime ;
    dct:language <http://id.loc.gov/vocabulary/iso639-1/en> ;
    dct:modified "2026-04-17T10:31:25.351247"^^xsd:dateTime ;
    dct:provenance [ a dct:ProvenanceStatement ;
            rdfs:label ""@en,
                ""@nl ] ;
    dct:publisher [ a foaf:Agent ;
            dct:identifier <https://identifier.overheid.nl/tooi/id/zbo/zb000114> ;
            vcard:hasEmail <mailto:info@zin.nl> ;
            foaf:homepage <https://www.zorginstituutnederland.nl/> ;
            foaf:name "Zorginstituut Nederland" ] ;
    dct:spatial <http://publications.europa.eu/resource/authority/country/NLD> ;
    dct:title ""@en,
        "Pakketadvies nivolumab-relatlimab (Opdualag) - huidkanker"@nl ;
    dct:type <http://publications.europa.eu/resource/authority/dataset-type/TEST_DATA> ;
    adms:versionNotes ""@en,
        ""@nl ;
    dcat:contactPoint [ a vcard:Kind ;
            vcard:fn "Zorginstituut Nederland" ;
            vcard:hasEmail <mailto:info@zinl.nl> ;
            vcard:hasURL <['https://www.zorginstituutnederland.nl/service/contact']> ] ;
    dcat:keyword "Huidkanker  melanoma "@nl,
        "Immunotherapie  checkpoint inhibitor combinatie "@nl,
        "Nivolumab-relatlimab  Opdualag  "@nl ;
    dcat:landingPage <https://www.zorginstituutnederland.nl/documenten/2023/10/24/standpunt---mammaprint-en-oncotype-dx-vergoede-zorg-voor-bepaalde-groep-vrouwen> ;
    dcat:theme <http://publications.europa.eu/resource/authority/data-theme/HEAL> ;
    foaf:page <https://www.zorginstituutnederland.nl/site/binaries/site-content/collections/documents/2024/05/23/pakketadvies-sluisgeneesmiddel-nivolumab-relatlimab-opdualag/Advies%2Bnivolumab-relatlimab%2B%28Opdualag%C2%AE%29%2Bvoor%2Bde%2Bbehandeling%2Bvan%2Bhuidkanker.pdf> ;
    dpv:hasPurpose dpv:PublicBenefit .

<http://example.org/unknown> a <http://data.europa.eu/eli/ontology#LegalResource> .

<http://id.loc.gov/vocabulary/iso639-1/en> a dct:LinguisticSystem .

<http://publications.europa.eu/resource/authority/access-right/PUBLIC> a dct:RightsStatement .

<http://publications.europa.eu/resource/authority/country/NLD> a dct:Location .

<https://www.zorginstituutnederland.nl/documenten/2023/10/24/standpunt---mammaprint-en-oncotype-dx-vergoede-zorg-voor-bepaalde-groep-vrouwen> a foaf:Document .

<https://www.zorginstituutnederland.nl/site/binaries/site-content/collections/documents/2024/05/23/pakketadvies-sluisgeneesmiddel-nivolumab-relatlimab-opdualag/Advies%2Bnivolumab-relatlimab%2B%28Opdualag%C2%AE%29%2Bvoor%2Bde%2Bbehandeling%2Bvan%2Bhuidkanker.pdf> a foaf:Document .